UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 135

Sortiert nach

The Role of TLR4 in Chemotherapy-Driven Metastasis

Cancer research (Chicago, Ill.), 2015-06, Vol.75 (12), p.2405-2410

Ran, Sophia

2015

Volltextzugriff (PDF)

Lymphatic Endothelial Cell Progenitors in the Tumor Microenvironment

Advances in experimental medicine and biology, 2020-01, Vol.1234, p.87-105

2020

Volltextzugriff (PDF)

Paclitaxel therapy promotes breast cancer metastasis in a TLR4-dependent manner

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19), p.5421-5434

2014

Volltextzugriff (PDF)

Th2 Cytokines IL-4, IL-13, and IL-10 Promote Differentiation of Pro-Lymphatic Progenitors Derived from Bone Marrow Myeloid Precursors

Stem cells and development, 2022-06, Vol.31 (11-12), p.322

2022

Volltextzugriff (PDF)

Tumor microenvironment restricts IL-10 induced multipotent progenitors to myeloid-lymphatic phenotype

PloS one, 2024-04, Vol.19 (4), p.e0298465-e0298465

2024

Volltextzugriff (PDF)

Macrophage-mediated lymphangiogenesis: the emerging role of macrophages as lymphatic endothelial progenitors

Cancers, 2012-09, Vol.4 (3), p.618-657

2012

Volltextzugriff (PDF)

Phosphatidylserine is a marker of tumor vasculature and a potential target for cancer imaging and therapy

International journal of radiation oncology, biology, physics, 2002-12, Vol.54 (5), p.1479-1484

2002

Volltextzugriff (PDF)

Lymphatic endothelial progenitors originate from plastic myeloid cells activated by toll-like receptor-4

PloS one, 2017-06, Vol.12 (6), p.e0179257-e0179257

2017

Volltextzugriff (PDF)

Inhibiting NADPH Oxidases to Target Vascular and Other Pathologies: An Update on Recent Experimental and Clinical Studies

Biomolecules (Basel, Switzerland), 2022-06, Vol.12 (6), p.823

2022

Volltextzugriff (PDF)

Tumor suppressor function of Rab25 in triple‐negative breast cancer

International journal of cancer, 2010-06, Vol.126 (12), p.2799-2812

2010

Volltextzugriff (PDF)

Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effect

Proceedings of the National Academy of Sciences - PNAS, 2004-08, Vol.101 (31), p.11432-11437

2004

Volltextzugriff (PDF)

New model of macrophage acquisition of the lymphatic endothelial phenotype

PloS one, 2012-03, Vol.7 (3), p.e31794-e31794

2012

Volltextzugriff (PDF)

Heritable modifiers of the tumor microenvironment influence nanoparticle uptake, distribution and response to photothermal therapy

Theranostics, 2020-01, Vol.10 (12), p.5368-5383

2020

Volltextzugriff (PDF)

Synergy of Nab-paclitaxel and Bevacizumab in Eradicating Large Orthotopic Breast Tumors and Preexisting Metastases

Neoplasia (New York, N.Y.), 2011-04, Vol.13 (4), p.327-IN14

2011

Volltextzugriff (PDF)

Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo

Blood, 1998-12, Vol.92 (11), p.4150-4166

1998

Volltextzugriff (PDF)

Novel role of immature myeloid cells in formation of new lymphatic vessels associated with inflammation and tumors

Journal of leukocyte biology, 2017-08, Vol.102 (2), p.253-263

2017

Volltextzugriff (PDF)

Vascular Endothelial Growth Factor Inhibits the Development of Dendritic Cells and Dramatically Affects the Differentiation of Multiple Hematopoietic Lineages In Vivo

Blood, 1998-12, Vol.92 (11), p.4150-4166

1998

Volltextzugriff (PDF)

Antitumor Effects of a Monoclonal Antibody that Binds Anionic Phospholipids on the Surface of Tumor Blood Vessels in Mice

Clinical cancer research, 2005-02, Vol.11 (4), p.1551-1562

2005

Volltextzugriff (PDF)

Anti‐VEGF‐A therapy reduces lymphatic vessel density and expression of VEGFR‐3 in an orthotopic breast tumor model

International journal of cancer, 2007-11, Vol.121 (10), p.2181-2191

2007

Volltextzugriff (PDF)

Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression

Oncogene, 2004-07, Vol.23 (33), p.5675-5681

2004

Volltextzugriff (PDF)

Tumor Angiogenesis

2012

Volltextzugriff (PDF)

Abstract 1700: TLR4 as a novel determinant of paclitaxel response in metastatic breast cancer

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.1700-1700

2011

Volltextzugriff (PDF)

Nab-paclitaxel Efficacy in the Orthotopic Model of Human Breast Cancer Is Significantly Enhanced By Concurrent Anti–Vascular Endothelial Growth Factor A Therapy

Neoplasia (New York, N.Y.), 2008-06, Vol.10 (6), p.613-623

2008

Volltextzugriff (PDF)

In vitro and in vivo Studies of a VEGF121/rGelonin Chimeric Fusion Toxin Targeting the Neovasculature of Solid Tumors

Proceedings of the National Academy of Sciences - PNAS, 2002-06, Vol.99 (12), p.7866-7871

2002

Volltextzugriff (PDF)

Abstract 1967: Nab-paclitaxel chemotherapy of breast tumors upregulates chemokines that increase chemotaxis of myeloid-lymphatic progenitors

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.1967-1967

2019

Volltextzugriff (PDF)

1 – 25 von 135

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(130)
Mit Volltextzugriff
(127)

Publikationsform

Sprache

Englisch
(134)
Japanisch
(23)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The Role of TLR4 in Chemotherapy-Driven Metastasis

Lymphatic Endothelial Cell Progenitors in the Tumor Microenvironment

Paclitaxel therapy promotes breast cancer metastasis in a TLR4-dependent manner

Th2 Cytokines IL-4, IL-13, and IL-10 Promote Differentiation of Pro-Lymphatic Progenitors Derived from Bone Marrow Myeloid Precursors

Tumor microenvironment restricts IL-10 induced multipotent progenitors to myeloid-lymphatic phenotype

Macrophage-mediated lymphangiogenesis: the emerging role of macrophages as lymphatic endothelial progenitors

Phosphatidylserine is a marker of tumor vasculature and a potential target for cancer imaging and therapy

Lymphatic endothelial progenitors originate from plastic myeloid cells activated by toll-like receptor-4

Inhibiting NADPH Oxidases to Target Vascular and Other Pathologies: An Update on Recent Experimental and Clinical Studies

Tumor suppressor function of Rab25 in triple‐negative breast cancer

Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effect

New model of macrophage acquisition of the lymphatic endothelial phenotype

Heritable modifiers of the tumor microenvironment influence nanoparticle uptake, distribution and response to photothermal therapy

Synergy of Nab-paclitaxel and Bevacizumab in Eradicating Large Orthotopic Breast Tumors and Preexisting Metastases

Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo

Novel role of immature myeloid cells in formation of new lymphatic vessels associated with inflammation and tumors

Vascular Endothelial Growth Factor Inhibits the Development of Dendritic Cells and Dramatically Affects the Differentiation of Multiple Hematopoietic Lineages In Vivo

Antitumor Effects of a Monoclonal Antibody that Binds Anionic Phospholipids on the Surface of Tumor Blood Vessels in Mice

Anti‐VEGF‐A therapy reduces lymphatic vessel density and expression of VEGFR‐3 in an orthotopic breast tumor model

Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression

Tumor Angiogenesis

Abstract 1700: TLR4 as a novel determinant of paclitaxel response in metastatic breast cancer

Nab-paclitaxel Efficacy in the Orthotopic Model of Human Breast Cancer Is Significantly Enhanced By Concurrent Anti–Vascular Endothelial Growth Factor A Therapy

In vitro and in vivo Studies of a VEGF121/rGelonin Chimeric Fusion Toxin Targeting the Neovasculature of Solid Tumors

Abstract 1967: Nab-paclitaxel chemotherapy of breast tumors upregulates chemokines that increase chemotaxis of myeloid-lymphatic progenitors

Suchergebnisse filtern